Search Tag: semaglutide

2024 17 Apr

Obesity is a global pandemic, with prevalence in the U.S. reaching 42.4% in 2018 and projected to rise to around 50% by 2030. It is linked to chronic medical conditions that increase morbidity and mortality, imposing a substantial burden on annual healthcare spending. Given the high prevalence and adverse impact of obesity on health and healthcare...Read more

2023 25 Aug

  In recent breakthrough research presented during a Hot Line session at ESC Congress 2023, semaglutide's effectiveness in improving symptoms and physical function related to heart failure and inducing greater weight loss was reported.   Nearly 50% of heart failure patients are affected by heart failure with preserved ejection fraction (HFpEF)....Read more

2023 04 Jul

A recent study conducted by researchers at University College Cork (UCC) and the University of Galway suggests that changing how we discuss obesity is necessary to enhance public understanding of the disease. The researchers propose that the term "obesity" should be renamed to facilitate better comprehension among the public and policymakers, ultimately...Read more

2023 19 Apr

A new study suggests that some anti-obesity medications can be produced and sold at much lower prices than their current high costs, making them more accessible worldwide. The study is published in Obesity.   Study authors highlight the need for a public health approach that prioritises improving access to medications instead of allowing...Read more